GW Pharma CEO: Need to take dangle of extra on advantages of cannabis-derived remedy
GW Pharmaceuticals CEO Justin Gover tell about the must know extra about what cannabis-derived remedy must provide with Jim Cramer.
GW Pharma CEO on recent cannabis-derived drug
GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says referring to the capacity forward for cannabis-derived treatment.